Home > Insider Trading > Filing (0000950170-25-098540)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1794546	Carlsmed Inc.	CARL	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1476171	Ii Robert Mittendorff	C/O Carlsmed, Inc. 1800 Aston Ave., Suite 100 Carlsbad CA 92008		No	No	No	No

Transaction Summary

Purchased:	1,333,333 shares	Avg. Price: $15.00	Total Value: $19,999,995.00
Number of Shares After Transactions:	931,452 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-07-24	3,680,506	$0.00	3,680,506	No	4	C	Indirect	See footnotes
Common Stock	Acquisiton	2025-07-24	1,333,333	$15.00	5,013,839	No	4	P	Indirect	See footnotes
Common Stock	Acquisiton	2025-07-24	2,376,472	$0.00	2,376,472	No	4	C	Indirect	See footnotes
Common Stock	Acquisiton	2025-07-24	931,452	$0.00	931,452	No	4	C	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnotes
No	4	P	Indirect	See footnotes
No	4	C	Indirect	See footnotes
No	4	C	Indirect	See footnotes

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2025-07-24	1,445,020	$0.00	1,445,020	$0.00
Common Stock	Series C Preferred Stock	Disposition	2025-07-24	2,235,486	$0.00	2,235,486	$0.00
Common Stock	Series B Preferred Stock	Disposition	2025-07-24	1,445,020	$0.00	1,445,020	$0.00
Common Stock	Series C Preferred Stock	Disposition	2025-07-24	931,452	$0.00	931,452	$0.00
Common Stock	Series C Preferred Stock	Disposition	2025-07-24	931,452	$0.00	931,452	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering without payment of additional consideration. The Preferred Stock had no expiration date.
Shares held by B Capital Global Growth III, L.P.
Shares held by B Capital Healthcare I, L.P.
Shares held by Hornet Co-Invest, L.P.
B Capital Group Management, LP is the manager of B Capital Global Growth III and B Capital Healthcare I. Hornet-Co-Invest Investors, Ltd. is the ultimate general partner of Hornet Co-Invest (Hornet Co-Invest, L.P., together with B Capital Healthcare I, L.P., and B Capital Global Growth III, L.P., "B Capital"). The Reporting Person is a general partner of B Capital Group Management, LP. The Reporting Person disclaims beneficial ownership of such stock, except to the extent of any pecuniary interest therein.